Liver stiffness measurement using FibroScan® is influenced by serum total bilirubin in acute hepatitis
- 5 June 2009
- journal article
- Published by Wiley in Liver International
- Vol. 29 (6) , 810-815
Abstract
Background: Liver stiffness measurement (LSM) using FibroScan® is accepted as a highly reproducible and accurate technique for assessment of liver fibrosis. However, several studies have indicated that the LSM value can be significantly influenced by major changes in aminotransferases in patients with chronic viral hepatitis and LSM is unreliable for diagnosing underlying liver cirrhosis in patients with acute liver damage. We aimed to determine biochemical factors influencing the LSM value in patients with acute hepatitis. Methods: From July to December 2007, a total of 60 patients with acute hepatitis of varying aetiologies were recruited prospectively. LSM and biochemical tests were performed at diagnosis and recovery from acute hepatitis. Results: The mean age of the patients (38 men and 22 women) was 40.7±15.4 years. The aetiology of acute hepatitis included hepatitis A virus in 31 patients, drug induced in 19 and hepatitis B virus in 10. The mean LSM value was 19.6 kPa at diagnosis and 15.9 kPa at recovery. Correlation analysis showed that the LSM value at diagnosis was significantly associated with platelet count (P=0.023), alanine aminotransferase (P=0.045), albumin (PP=0.004) and prothrombin time (P=0.005). However, additional correlation analysis between the changes in LSM value and biochemical factors from diagnosis to recovery showed that the change in total bilirubin was found to be the only factor associated with the change in the LSM value (P<0.001). Conclusions: Our data suggest that the LSM value might be influenced by serum total bilirubin in patients with acute hepatitis without pre‐existing underlying chronic liver disease.Keywords
This publication has 18 references indexed in Scilit:
- Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosisLiver International, 2008
- Acute viral hepatitis increases liver stiffness values measured by transient elastographyHepatology, 2008
- Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis BLiver International, 2007
- Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminasesJournal of Viral Hepatitis, 2006
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative studyHepatology, 2002
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Special issue : Digestive system lesion due to drug inducement.Digestive system lesion due to drug inducement.Advance on diagnosis and treatment.Pathology of drug-induced hepatic injury - on difference with the viral hepatic disorder.Nihon Naika Gakkai Zasshi, 1995
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986